4-Substituted-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine Derivatives: Design, Synthesis, Antitumor and EGFR Tyrosine Kinase Inhibitory Activity

被引：19

作者：

Abbas, Safinaz E. -S. ^{[1
]}

Aly, Enayat I. ^{[1
]}

Awadallah, Fadi M. ^{[1
]}

Mahmoud, Walaa R. ^{[1
]}

机构：

[1] Cairo Univ, Dept Pharmaceut Chem, Fac Pharm, Cairo 11562, Egypt

来源：

CHEMICAL BIOLOGY & DRUG DESIGN | 2015年 / 85卷 / 05期

关键词：

antitumor; EGFR-TK inhibition; molecular modeling; pyrazolo[3; 4-d]pyrimidines; synthesis; ANTIPROLIFERATIVE ACTIVITY; CANCER; AGENTS; STRATEGY; DOCKING; CELLS; A431;

D O I：

10.1111/cbdd.12451

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Four series of some 4-substituted-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine derivatives 5a-f, 6a-f, 8a-f, and 9a-f were designed to be screened for their antitumor activity. All compounds were evaluated against breast (MCF-7) and lung (A-549) cell lines. Six compounds 5a, 5b, 6b, 6e, 9e, and 9f displaying activity against both cell lines were further estimated for their EGFR-TK inhibitory activity where they revealed 41-91% inhibition and compound 6b elicited the highest activity (91%). A docking study of these compounds into the ATP-binding site of EGFR-TK demonstrated their binding mode where H-bonding interaction with Met793 through N-1 of pyrimidine or N-2 of pyrazole was observed.

引用

页码：608 / 622

页数：15

共 34 条

[1] Synthesis of novel pyrazolo[3,4-d]pyrimidine derivatives as potential anti-breast cancer agents [J].

Abd El Hamid, Mohammed K. ;

Mihovilovic, Marko D. ;

El-Nassan, Hala B. .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 57 :323-328

[2] Novel benzimidazole-pyrimidine conjugates as potent antitumor agents [J].

Abdel-Mohsen, Heba T. ;

Ragab, Fatma A. F. ;

Ramla, Mostafa M. ;

El Diwani, Hoda I. .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (06) :2336-2344

[3] Synthesis and biological evaluation of novel 2,4′-bis substituted diphenylamines as anticancer agents and potential epidermal growth factor receptor tyrosine kinase inhibitors [J].

Abou-Seri, Sahar Mahmoud .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (09) :4113-4121

[4] Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase [J].

Abouzid, Khaled ;

Shouman, Samia .

BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (16) :7543-7551

[5] EGFR tyrosine kinase targeted compounds: synthesis, docking study, and in vitro antitumor activity of some new quinazoline and benzo[d]isothiazole derivatives [J].

Amin, Kamelia M. ;

Georgey, Hanan H. ;

Awadallah, Fadi M. .

MEDICINAL CHEMISTRY RESEARCH, 2011, 20 (07) :1042-1053

[6] Multitarget-directed drug design strategy: A novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects [J].

Antonello, Alessandra ;

Tarozzi, Andrea ;

Morroni, Fabiana ;

Cavalli, Andrea ;

Rosini, Michela ;

Hrelia, Patrizia ;

Bolognesi, Maria Laura ;

Melchiorre, Carlo .

JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (23) :6642-6645

[7] Oncogenic kinase signalling [J].

Blume-Jensen, P ;

Hunter, T .

NATURE, 2001, 411 (6835) :355-365

[8]

Borenfreund E, 1985, J TISSUE CULT METHOD, V9, P7, DOI [DOI 10.1007/BF01666038, 10.1007/BF01666038]

[9] Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2) [J].

Carlomagno, F ;

Vitagliano, D ;

Guida, T ;

Basolo, F ;

Castellone, MD ;

Melillo, RM ;

Fusco, A ;

Santoro, M .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04) :1897-1902

[10]

Carlomagno F, 2002, CANCER RES, V62, P1077

← 1 2 3 4 →